Spots Global Cancer Trial Database for pulmonary
Every month we try and update this database with for pulmonary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components | NCT02549222 | Transfusion Rel... | Standard of Car... | - | Cerus Corporation | |
| Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment | NCT05041140 | Pulmonary Pneumonia Hematopoietic S... | 29-XeMRI imagin... | 18 Years - | M.D. Anderson Cancer Center | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. | NCT04276597 | Pulmonary Neuro... Pheochromocytom... Paraganglioma Thymus Carcinoi... Unknown Primary... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... | 177Lu-DOTATOC | 18 Years - | Excel Diagnostics and Nuclear Oncology Center | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | NCT00241267 | Pulmonary Neopl... | Dedicated ultra... | 18 Years - | University Hospital, Tours | |
| Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment | NCT05041140 | Pulmonary Pneumonia Hematopoietic S... | 29-XeMRI imagin... | 18 Years - | M.D. Anderson Cancer Center | |
| Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors | NCT04450927 | Wide Spectrum o... Hematologic Dis... | 2 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma | NCT05726383 | Osteogenic Sarc... | Iscador*P | 8 Years - 30 Years | Hackensack Meridian Health | |
| Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer | NCT00098085 | Non-Small-Cell ... Lung Cancer Pulmonary Cance... | HSPPC-96 | 18 Years - | Agenus Inc. | |
| Radiofrequency Ablation of Malignant Pulmonary Nodules | NCT02629978 | Neoplasms Carcinoma | CT-guided percu... | - | Chinese PLA General Hospital | |
| Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment | NCT05041140 | Pulmonary Pneumonia Hematopoietic S... | 29-XeMRI imagin... | 18 Years - | M.D. Anderson Cancer Center | |
| Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma | NCT05726383 | Osteogenic Sarc... | Iscador*P | 8 Years - 30 Years | Hackensack Meridian Health | |
| Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2) | NCT00886353 | Pulmonary Disea... Cardiovascular ... Kidney Diseases Cancer Diseases | APN01 Placebo | 18 Years - | Apeiron Biologics | |
| Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | NCT00241267 | Pulmonary Neopl... | Dedicated ultra... | 18 Years - | University Hospital, Tours | |
| Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. | NCT04276597 | Pulmonary Neuro... Pheochromocytom... Paraganglioma Thymus Carcinoi... Unknown Primary... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... | 177Lu-DOTATOC | 18 Years - | Excel Diagnostics and Nuclear Oncology Center | |
| Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | NCT00241267 | Pulmonary Neopl... | Dedicated ultra... | 18 Years - | University Hospital, Tours | |
| Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer | NCT01545947 | Carcinoma, Non-... Non-Small Cell ... | CC-223, erlotin... CC-223, oral az... CC-223, oral az... | 18 Years - | Celgene |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
